Results 231 to 240 of about 5,799,531 (403)

Prognostic Impact of Tumor Size in Patients with Stage T3N1 Colon Cancer. [PDF]

open access: yesJ Clin Med
Turkoglu E   +12 more
europepmc   +1 more source

Parameters of radical resection in laparoscopic and open colon and rectal cancer surgery

open access: gold, 2018
Igor Krdžić   +5 more
openalex   +2 more sources

Tumor Sidedness Could be a High-risk Factor in Patients with Stage II Colon Cancer [PDF]

open access: green, 2020
Kenta Iguchi   +10 more
openalex   +1 more source

Regulating Tumor Metabolic Reprogramming with Biomimetic Co‐Delivery of Simvastatin and Kynureninase for Immunotherapy

open access: yesAdvanced Science, EarlyView.
After the intravenous injection of biomimetic and pH/ROS‐responsive PTSK@CRM, the nanoparticles can be accumulated in tumors and release Sim and KYNase to inhibit the tumor growth, regulate the metabolism of cholesterol and Kyn, and reverse the immunosuppressive tumor microenvironment.
Jiaxin Yin   +6 more
wiley   +1 more source

FSTL1 is a prognostic marker and promotes invasion and metastasis of colon cancer. [PDF]

open access: yesDiscov Oncol
Zhong C   +8 more
europepmc   +1 more source

Ribosome Homeostasis Regulated by SETD2 Preserves Intestinal Epithelial Barrier

open access: yesAdvanced Science, EarlyView.
SETD2 ablation causes dysregulation and recruitment defects of ribosome biogenesis factors, resulting in translational disorders of barrier maintenance genes, thereby compromising the intestinal barrier. These findings unveil a previously unappreciated role of ribosome biogenesis and translational regulation in preserving the intestinal epithelial ...
Hanyu Rao   +11 more
wiley   +1 more source

Comparative assessment of results of D2 and D3 lymph node dissections in term of colon cancer surgery

open access: diamond, 2022
Oleg I. Kit   +5 more
openalex   +2 more sources

Metformin Impairs Breast Cancer Growth through the Inhibition of PRMT6

open access: yesAdvanced Science, EarlyView.
Metformin has a biological activity against breast cancer. However, it is largely unknown about its precise therapeutic targets. Here, histone arginine methyltransferase PRMT6 is identified as a new anti‐cancer target for metformin. Metformin directly binds PRMT6 and inhibits its ability to catalyze histone H3R2 asymmetric dimethylation (H3R2me2a ...
Yinsheng Wu   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy